Follow
Jason D Limberis
Title
Cited by
Cited by
Year
Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable …
K Dheda, JD Limberis, E Pietersen, J Phelan, A Esmail, M Lesosky, ...
The lancet Respiratory medicine 5 (4), 269-281, 2017
1242017
Xpert MTB/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results?
G Theron, R Venter, G Calligaro, L Smith, J Limberis, R Meldau, ...
Clinical Infectious Diseases 62 (8), 995-1001, 2016
1202016
Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa
O Olayanju, J Limberis, A Esmail, S Oelofse, P Gina, E Pietersen, M Fadul, ...
European Respiratory Journal 51 (5), 2018
772018
The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis
K Dheda, T Gumbo, G Maartens, KE Dooley, M Murray, J Furin, ...
The Lancet Respiratory Medicine 7 (9), 820-826, 2019
582019
Same-day tools, including Xpert Ultra and IRISA-TB, for rapid diagnosis of pleural tuberculosis: a prospective observational study
R Meldau, P Randall, A Pooran, J Limberis, E Makambwa, M Dhansay, ...
Journal of clinical microbiology 57 (9), e00614-19, 2019
232019
A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug-resistant tuberculosis
O Olayanju, A Esmail, J Limberis, K Dheda
European Respiratory Journal 55 (1), 2020
202020
Linezolid interruption in patients with fluoroquinolone-resistant tuberculosis receiving a bedaquiline-based treatment regimen
O Olayanju, A Esmail, J Limberis, P Gina, K Dheda
International Journal of Infectious Diseases 85, 74-79, 2019
172019
A Human lung challenge model to evaluate the safety and immunogenicity of PPD and live bacillus Calmette-Guérin
M Davids, A Pooran, C Hermann, L Mottay, F Thompson, J Cardenas, ...
American journal of respiratory and critical care medicine 201 (10), 1277-1291, 2020
132020
Selected questions and controversies about bedaquiline: a view from the field
K Dheda, A Esmail, J Limberis, G Maartens
The International Journal of Tuberculosis and Lung Disease 20 (12), S24-S32, 2016
132016
Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis
G Theron, J Limberis, R Venter, L Smith, E Pietersen, A Esmail, ...
Nature medicine 26 (9), 1435-1443, 2020
122020
A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic
M Klopper, TH Heupink, G Hill-Cawthorne, EM Streicher, A Dippenaar, ...
BMC medicine 18 (1), 1-14, 2020
112020
Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis
CC Naidoo, GR Nyawo, I Sulaiman, BG Wu, CT Turner, K Bu, Z Palmer, ...
EBioMedicine 67, 103374, 2021
72021
Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis
N Ismail, E Rivière, J Limberis, S Huo, JZ Metcalfe, RM Warren, A Van Rie
The Lancet Microbe 2 (11), e604-e616, 2021
22021
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
SB Georghiou, TC Rodwell, A Korobitsyn, SH Abbadi, K Ajbani, ...
European Respiratory Journal 59 (4), 2022
2022
Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosis
MG Whitfield, DM Engelthaler, C Allender, M Folkerts, TH Heupink, ...
Journal of Clinical Microbiology 60 (1), e01907-21, 2021
2021
M. tuberculosis resides in permissive, lysosome-poor recruited macrophages during chronic infection
W Zheng, IC Chang, J Limberis, F Ning, J Ernst
The Journal of Immunology 206 (1 Supplement), 99.09-99.09, 2021
2021
Differential RD-1-specific IFN-γ host responses to diverse Mycobacterium tuberculosis strains in HIV-uninfected persons may be explained by genotypic variation in the ESX-1 region
M Tomasicchio, J Limberis, R van der Merwe, R Jacobson, R Meldau, ...
International Journal of Infectious Diseases 96, 240-243, 2020
2020
Outcomes, Infectiousness And Transmission Dynamics Of Patients With Extensively Drug Resistant Tuberculosis And Home-Discharged Patients With Programmatically Incurable Tb: A …
JD Limberis, E Pietersen, J Phelan, A Esmail, M Lesosky, KP Fennelly, ...
D96. INFECTIOUSNESS AND TRANSMISSION OF TUBERCULOSIS, A7320-A7320, 2017
2017
Bacterial And Host Determinants Of Infectiousness In Patients With Drug-Susceptible Or Drug-Resistant Tuberculosis
G Theron, L Smith, JD Limberis, R Venter, A Esmail, R McNerney, ...
D96. INFECTIOUSNESS AND TRANSMISSION OF TUBERCULOSIS, A7319-A7319, 2017
2017
D96 INFECTIOUSNESS AND TRANSMISSION OF TUBERCULOSIS: Outcomes, Infectiousness And Transmission Dynamics Of Patients With Extensively Drug Resistant Tuberculosis And Home …
JD Limberis, E Pietersen, J Phelan, A Esmail, M Lesosky, KP Fennelly, ...
American Journal of Respiratory and Critical Care Medicine 195, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–20